lobbying_activities: 1552357

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1552357	416efc63-174e-426a-b3a5-347cd1163b9e	Q2	AMERICAN CLINICAL LABORATORY ASSN	1923	AMERICAN CLINICAL LABORATORY ASSN	2014	second_quarter	MED	Reimbursement and coverage issues related to the Medicare Clinical Laboratory Fee Schedule and the Physician Fee Schedule, including implementation of the Protecting Access to Medicare Act of 2014(P.L. 113-93), misvalued codes, and pricing for molecular diagnostic tests by CMS. Proposed FDA regulation of laboratory-developed tests. Narrowing the In-Office Ancillary Services Exception to the federal self-referral statute to remove anatomic pathology, advanced diagnostic imaging, physical therapy, and radiation therapy services, H.R. 2914, the Promoting Integrity in Medicare Act of 2013. 21st Century Cures Initiative.	Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Defense, Dept of (DOD),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),Office of Management & Budget (OMB),SENATE,White House Office		273317	0	0	2014-07-16T10:55:02.500000-04:00